Stock Ticker

  • Loading stock data...

Inovio Pharmaceuticals Inc (NASDAQ:INO) Is Now Offering Common Stock To the Public For The Acquire

The current developments have shown that Inovio Pharmaceuticals Inc (NASDAQ:INO) has finally accepted to sell its shares to the public after a very long period of time of anticipation from the public. According to different sources, Inovio has already announced the pricing of underwritten public offering of 12,500,000 shares of its common stocks will be […]

Inovio Pharmaceuticals, Inc. (NASDAQ:INO), To Continue INO-1800 Development Amid Roche Holding Ltd. (OTCMKTS:RHHBY) Ditching

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) has revealed on Wednesday that it will continue to independently develop INO-1800, a hepatitis B DNA immunotherapy, after Roche Holding Ltd. (OTCMKTS:RHHBY) decided to entirely discontinue collaborating with the company. Inovio’s Plans for INO-1800 Development The company will proceed with the randomized, open-label, active-controlled Phase I clinical trial of INO-1800 in […]

Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock

Boston, MA 05/27/2014 (wallstreetpr) – Inovio Pharmaceuticals Inc (NYSEMKT:INO) is developing vaccines for the treatment of cancers and other serious diseases through its patented synthetic vaccine technology. The Company primarily generates revenue from its collaborative R&D projects with major pharma players and grants from the government programs. Highlights Of First Quarter During the first quarter […]

Sign Up To Get Our Latest Stocks Alerts